Jaroslaw Kuzdzal
Overview
Explore the profile of Jaroslaw Kuzdzal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
1348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trybalski L, Szadurski J, Kuzdzal J, Galas A, Janczura M, Warmus J, et al.
J Thorac Dis
. 2024 Sep;
16(8):4977-4985.
PMID: 39268115
Background: Bilateral lymph node dissection is not a standard surgical treatment for non-small cell lung carcinoma. However, data from anatomical studies showing lymph flow to the contralateral mediastinal lymph nodes...
2.
Trybalski L, Szadurski J, Zhang L, Kuzdzal J, Turna A, Wang W, et al.
J Cardiothorac Surg
. 2024 Jul;
19(1):412.
PMID: 38956617
Background: This study evaluated the prevalence and quantity of lymph nodes at particular stations of the mediastinum in patients with lung cancer. These data are important to radiologists, pathologists, and...
3.
Cascone T, Awad M, Spicer J, He J, Lu S, Sepesi B, et al.
N Engl J Med
. 2024 May;
390(19):1756-1769.
PMID: 38749033
Background: Standard treatment with neoadjuvant nivolumab plus chemotherapy significantly improves outcomes in patients with resectable non-small-cell lung cancer (NSCLC). Perioperative treatment (i.e., neoadjuvant therapy followed by surgery and adjuvant therapy)...
4.
Stepien K, Skorek P, Wlodarczyk J, Wojcik J, Smeder T, Trybalski L, et al.
Adv Clin Exp Med
. 2022 Mar;
31(3):337-344.
PMID: 35349229
Background: Primary melanoma of the esophagus (PME) represents a rare type of gastrointestinal malignancy with an exceptionally poor diagnosis. So far, only few descriptions of PME which satisfactorily summarize their...
5.
Piwkowski C, Gabryel P, Orlowski T, Kowalewski J, Kuzdzal J, Rzyman W
Pol Arch Intern Med
. 2022 Jan;
132(2).
PMID: 35023697
No abstract available.
6.
7.
Kuzdzal J, Trybalski L, Hauer L, Cmiel A, Grochowski Z, Szadurski J, et al.
Lung Cancer
. 2021 May;
156:140-146.
PMID: 33962764
Objectives: This study aimed to analyze the effect of bilateral mediastinal lymphadenectomy (BML) on survival of non-small cell lung cancer (NSCLC) patients. The hypothesis was: BML offers survival benefit as...
8.
Kelly R, Ajani J, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, et al.
N Engl J Med
. 2021 Mar;
384(13):1191-1203.
PMID: 33789008
Background: No adjuvant treatment has been established for patients who remain at high risk for recurrence after neoadjuvant chemoradiotherapy and surgery for esophageal or gastroesophageal junction cancer. Methods: We conducted...
9.
Chytrosz P, Golda-Cepa M, Wlodarczyk J, Kuzdzal J, El Fray M, Kotarba A
ACS Biomater Sci Eng
. 2021 Mar;
7(4):1403-1413.
PMID: 33709689
Partially covered self-expandable metallic esophageal stent (SEMS) placement is the most frequently applied palliative treatment in esophageal cancer. Structural characterization of explanted 16 nitinol-polyurethane SEMS (the group of 6 females,...
10.
Misiaszek M, Gnass M, Rudnicka L, Soja J, Kuzdzal J, Szlubowski A
Pol Arch Intern Med
. 2020 May;
130(6):550-552.
PMID: 32420707
No abstract available.